LTIMINDTREE
17.1.2024 15:19:34 CET | Business Wire | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the third quarter ended December 31, 2023, as approved by its Board of directors.
“Our strong operational performance in a seasonally weak quarter speaks about the organization’s resilience amid the continuing macro challenges. For the quarter, we reported a revenue of USD 1.08 billion, a 3.5% YoY growth in USD terms, an EBIT margin of 15.4%, an increase of 150 bps YoY, and a PAT margin of 13%, an increase of 140 bps YoY.
We have booked our highest-ever order inflow at USD 1.5 billion, representing a 21% increase YoY, and our strong cash flow metrics helped us cross INR 10,000 crore in cash and investment balance. These strong indicators make us confident to deliver on our path to success as we enter the new year.”
-Debashis Chatterjee, Chief Executive Officer and Managing Director
Key financial highlights:
Quarter ended December 31, 2023
- In USD:
- Revenue at $1,083.7 million (growth of 0.8% Q-o-Q / 3.5% Y-o-Y)
- Net profit at $140.5 million (growth of 0.1% Q-o-Q / 15.6% Y-o-Y)
- In INR:
- Revenue at Rs 90,166 million (growth of 1.2% Q-o-Q / 4.6% Y-o-Y)
- Net profit at Rs 11,693 million (growth of 0.6% Q-o-Q / 16.8% Y-o-Y)
Nine Months ended December 31, 2023 (YTD FY24 vs YTD FY23)
- In USD:
- Revenue at $3,217.9 million (growth of 5.6%)
- Net profit at $421.1 million (growth of 2.7%)
- In INR:
- Revenue at Rs 2,66,241 million (growth of 8.7%)
- Net profit at Rs 34,839 million (growth of 5.7%)
Other highlights:
- Clients:
- 739 active clients as of December 31, 2023
- $5 million+ clients increased by 5 on a Y-o-Y basis, total 149
- $10 million+ clients increased by 8 on a Y-o-Y basis, total 89
- $20 million+ clients increased by 3 on a Y-o-Y basis, total 40
- $50 million+ clients increased by 1 on a Y-o-Y basis, total 12
- People:
- 82,471 professionals as of December 31, 2023
- Trailing 12 months attrition was 14.2%
Deal Wins
- A global leader in the design, engineering, and delivery of customized facilities for high-tech industries has selected LTIMindtree as their preferred strategic partner for their Digital Transformation journey over the next 5 years. LTIMindtree will drive transformation across the technology landscape through multiple services including Cloud Migration, End User Services, Security, and Application Development and Support.
- A US-based premier oil and gas producer selected LTIMindtree as their strategic partner for end-to-end technology services. As part of the partnership, LTIMindtree will provide services across several value-based portfolios covering Digital Solutions, Platforms and Operations.
- A diversified multinational mass media corporation has chosen LTIMindtree as their preferred ServiceNow transformation partner. This engagement will help unlock the value of their ServiceNow investments, improve ROI, and drive cost efficiency.
- A leading US-based energy producer has expanded its infrastructure managed services scope with LTIMindtree.
- A global financial services technology company has chosen LTIMindtree for its Product Development initiatives.
- A utilities company in the Middle East continues to strengthen its relationship with LTIMindtree by signing another 3-year agreement where LTIMindtree will support their transformation journey by identifying areas of expansion and optimizing the technology landscape.
Partnerships
- LTIMindtree received the "Global Partner of the Year award" for Sustainability from #AWS at #reinvent2023. We received this commendation for the business impact we created for one of our marquee Utility customers, enabling them to reduce over 2 million metric tonnes of carbon emissions. This recognition accentuates LTIMindtree as a conscientious, futuristic, and sustainable organization committed to an inclusive vision, shared growth, and positive value creation with our stakeholders.
- LTIMindtree was honoured with "Partner on Boomi Award" at the Boomi World Tour. This recognition endorses LTIMindtree’s deep expertise to deliver integrated environments, power automation, and enable data-driven decision-making to give our joint customers the best business outcomes.
Recognitions
- LTIMindtree named Global Future 50 Company by Fortune Magazine in its latest edition, being the only IT Services company to feature on the list.
- LTIMindtree positioned as a Leader in Everest Group's Cloud Services in Insurance PEAK Matrix® Assessment 2024.
- LTIMindtree recognized as Leader and Star Performer in Everest Group's Talent Readiness for Next-gen IT Services PEAK Matrix 2023.
- LTIMindtree recognized as Leader in Everest Group's Lending Services 2023 PEAK Assessment.
- LTIMindtree recognized in Forrester's ‘The Application Modernization and Migration Services Landscape, Q4 2023’.
- LTIMindtree interviewed for Forrester's November 2023 report, ‘Layers, Gates, Pipes, And Loops: A GenAI Application Architecture’.
- LTIMindtree recognized in Forrester’s ‘The Continuous Automation and Testing Services Landscape, Q4 2023’.
- LTIMindtree recognized in Forrester’s ‘The Microsoft Business Applications Services Landscape, Q4 2023’.
- LTIMindtree recognized as an Enterprise Innovator in HFS Horizons: Generative Enterprise Services Horizons.
- LTIMindtree recognized as an Enterprise Innovator in HFS Horizons: Life science service providers 2023.
- LTIMindtree positioned as an Innovator in HFS Horizon's Retail & CPG Industry 2023.
- LTIMindtree positioned as a Rising Star in ISG Supply Chain Services 2023.
- LTIMindtree positioned as a Major Contender in Everest Group's Cloud Security Services PEAK Matrix® Assessment 2023.
- LTIMindtree recognized as a Major Contender in Everest Group's Digital Interactive Experience (IX) Services PEAK Matrix® Assessment 2023 – North America.
- LTIMindtree recognized as a Major Contender in Everest Group’s Artificial Intelligence (AI) Services PEAK Matrix® Assessment 2023.
- LTIMindtree recognized as a Major Contender in Everest Group's Healthcare Digital Payer Services PEAK Assessment 2023.
About LTIMindtree
LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 82,000+ talented and entrepreneurial professionals across more than 30 countries, LTIMindtree — a Larsen & Toubro Group company — combines the industry-acclaimed strengths of erstwhile Larsen and Toubro Infotech and Mindtree in solving the most complex business challenges and delivering transformation at scale. For more information, please visit https://www.ltimindtree.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240117482620/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
